Hanmi Financial: A Clash of Institutional Titans
30.11.2025 - 17:41:05Hanmi US4104952043
Significant shifts are occurring within Hanmi Financial Corporation's shareholder base as major institutions take opposing stances on the regional bank's prospects. The landscape reveals a fascinating divergence of opinion, with one prominent investor executing a substantial withdrawal while several other asset managers significantly increase their holdings.
The investment community was taken aback when SG Americas Securities LLC slashed its stake in Hanmi Financial by a striking 48.4% during the second quarter. This transaction, involving the sale of 12,293 shares, leaves the firm with a diminished holding of just 13,113 shares. This decisive reduction stands in sharp contrast to the actions of other institutional players.
Despite this notable departure, institutional ownership remains substantial at 88.66%. LSV Asset Management emerged as a particularly bullish counterpart, aggressively expanding its position to control 1.38 million shares. Other financial heavyweights including Allianz, Invesco, and Charles Schwab also raised their investments in the company, creating a clear divide in institutional sentiment.
Strong Financial Performance Underpins Debate
Hanmi's recent quarterly results provided compelling evidence for the optimistic camp. The company reported earnings of $0.73 per share, comfortably exceeding analyst projections by $0.07. Revenue figures similarly impressed, reaching $70.96 million against expectations of $67.80 million.
The bank's fundamental metrics demonstrate robust financial health. A net margin of 16.53% and return on equity of 9.59% reflect solid profitability. Shareholders continue to benefit from consistent income through quarterly distributions of $0.27 per share, translating to an attractive annual dividend yield of 3.9%.
Should investors sell immediately? Or is it worth buying Hanmi?
Divided Analyst Perspectives Emerge
Market experts display varying degrees of enthusiasm toward Hanmi's outlook. The consensus rating currently stands at "Moderate Buy" with an average price target of $28.50. However, this masks underlying disagreements among research firms.
Zacks Research upgraded its assessment to "Strong Buy" on October 23, while Wall Street Zen adopted a more cautious stance by downgrading the stock to "Hold" on November 23. In a significant move, Keefe, Bruyette & Woods raised its price objective from $29.00 to $30.50, despite maintaining a "Market Perform" rating on the shares.
With a market capitalization of $827.81 million and a price-to-earnings ratio of 11.56, the valuation appears reasonable. The stock's beta of 0.75 suggests it may experience less volatility than the broader market.
Balance Sheet Strength Provides Foundation
Hanmi's financial stability is evidenced by several key ratios:
- Quick Ratio: 0.97
- Current Ratio: 0.97
- Debt-to-Equity: 0.25
- CET1 Ratio: 12.00% (as of September 30, 2025)
- Total Capital Ratio: 15.05% (as of September 30, 2025)
These metrics substantially surpass regulatory minimum requirements, indicating a well-capitalized institution with a resilient financial foundation. This strength forms the core argument for investors maintaining confidence despite the conflicting signals from major shareholders.
Ad
Hanmi Stock: Buy or Sell?! New Hanmi Analysis from November 30 delivers the answer:
The latest Hanmi figures speak for themselves: Urgent action needed for Hanmi investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 30.
Hanmi: Buy or sell? Read more here...


